Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03522324 · ClinicalTrials.gov registry record
Pain Research: Innovative Strategies With Marijuana
A clinical trial, sponsored by University of Colorado, Boulder.
- Completed
- Registry status
- 268
- Enrollment target
NCT03522324 is a clinical trial that has completed, run by University of Colorado, Boulder. The registered enrollment target is 268 participants.
The verdict
NCT03522324 has completed, sponsored by University of Colorado, Boulder.
- COMPLETED
- Registry status
- 268 participants
- Enrollment target
Study Summary
This study tests the effects of cannabinoid levels in blood on pain relief, inflammation, and cognitive dysfunction in chronic pain patients who choose to use edible cannabis. Over a two-week period, participants use an edible product of their choice. Blood levels of 9-delta-tetrahydrocannabinol (THC) and cannabidiol (CBD) will be measured before, during, and after the two-week exposure period to determine whether there are associations with pain, inflammation, sleep, physical activity, anxiety/depression, and cognitive dysfunction. After the two-week self-administration period, participants will be followed for six months to collect self-report data on cannabis use, pain levels, sleep quality, and mental health symptoms.
Interventions
- DRUG Cannabis Edible
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 268 participants |
| Start Date | 2018-06-01 |
| Est. Completion | 2023-10-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03522324
The ClinicalTrials.gov registry entry for NCT03522324 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 268 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Boulder, which has 69 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cannabis Edible is the first listed.
NCT03522324 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03522324 about?
NCT03522324 is a clinical study titled "Pain Research: Innovative Strategies With Marijuana". This study tests the effects of cannabinoid levels in blood on pain relief, inflammation, and cognitive dysfunction in chronic pain patients who choose to use edible cannabis. Over a two-week period, participants use an edible product of their choice. Blood levels of 9-delta-tetrahydrocannabinol (TH...
What is the current status of trial NCT03522324?
This trial is currently completed. The enrollment target is 268 participants. The study started on 2018-06-01. Estimated completion is 2023-10-12.
What interventions are being tested in trial NCT03522324?
The interventions under investigation include: Cannabis Edible (DRUG).
Who is sponsoring clinical trial NCT03522324?
This trial is sponsored by University of Colorado, Boulder, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.